Budget Amount *help |
¥17,940,000 (Direct Cost: ¥13,800,000、Indirect Cost: ¥4,140,000)
Fiscal Year 2022: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2021: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2020: ¥8,450,000 (Direct Cost: ¥6,500,000、Indirect Cost: ¥1,950,000)
|
Outline of Final Research Achievements |
Dopaminergic transmission is essential for our normal brain function, and its dysfunction causes many brain disorders such as Parkinson's disease and schizophrenia. However, our current knowledge is not sufficient about where dopamine is released from and what it targets to, and how it functions on its target cells. To address these questions, we newly developed a genome editing-based platform to visualize molecularly-defined dopamine release sites and simultaneously introduce Cre recombinase for neuronal labeling or manipulation in the same neurons in mammalian brains.
|